[Non-classical hormones from the fibroblast growth factor family]. [PDF]
Probl Endokrinol (Mosk)Gronskaia SA +3 more
europepmc +1 more source
[Features of the relationship of intestinal microbiota indicators with clinical and biochemical parameters in obese young people]. [PDF]
Probl Endokrinol (Mosk)Dushina TS +4 more
europepmc +1 more source
[The relationship between Parkinson's disease and metabolic disorders: the impact of systemic dysfunctions on neurodegeneration]. [PDF]
Probl Endokrinol (Mosk)Yusupov FA, Abdykadyrov MS.
europepmc +1 more source
[Arterial mediacalcinosis in patients with diabetes mellitus: etiopathogenetic and histopathological aspects]. [PDF]
Probl Endokrinol (Mosk)Bondarenko ON +3 more
europepmc +1 more source
[Features of bioenergetic metabolism in physiological and pathological conditions: focus on oncogenesis]. [PDF]
Probl Endokrinol (Mosk)Zhdanova AS, Belaya ZE, Melnichenko GA.
europepmc +1 more source
Insulin glargine 100 U/ml (iGla) is gradually giving way to a fixed combination of insulin glargine 100 U/ml+ lixisenatide (iGlaLixi) - an effective and safe drug for Diabetes Mellitus Type 2 (DM2T) control.
Дьяков И.Н. +1 more
core
[Features of glycemic variability in men with different types of obesity]. [PDF]
Probl Endokrinol (Mosk)Sorokin MY +3 more
europepmc +1 more source
[Metastatic pituitary lesion]. [PDF]
Probl Endokrinol (Mosk)Lapshina AM +8 more
europepmc +1 more source
[Factors and conditions affecting transcortin production and function in blood plasma]. [PDF]
Probl Endokrinol (Mosk)Chevais A +7 more
europepmc +1 more source
[The role of leptin in endometrium disorders: literature review]. [PDF]
Probl Endokrinol (Mosk)Ievleva KD, Danusevich IN, Suturina LV.
europepmc +1 more source